Congress Asset Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Congress Asset Management's EDIT Position: Q4 2024 in Review
Congress Asset Management sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 89,557 shares — an estimated $305K sold.
Congress Asset Management first reported a position in EDIT in Q1 2021 and held it in 15 quarters. The position peaked at $3.86M in Q2 2021. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.
- Congress Asset Management reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
- Congress Asset Management sold 89,557 Editas Medicine shares in Q4 2024, an estimated $305K.
- Congress Asset Management first reported a position in Editas Medicine in Q1 2021 and held it in 15 quarters.
- Congress Asset Management's Editas Medicine position peaked at $3.86M in Q2 2021.
- 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.
Based on Congress Asset Management's 13F filing for Q4 2024, filed 30 Jan 2025.